Macorate CR 200 Tablet contains Magnesium Valproate 200 mg, an anticonvulsant and mood-stabilizing agent primarily used in the management of epilepsy, bipolar disorder, and migraine prophylaxis. Magnesium Valproate acts by increasing the availability of gamma-aminobutyric acid (GABA) in the brain, which helps to stabilize neuronal activity and prevent abnormal electrical discharges associated with seizures. The controlled-release formulation ensures a steady release of the active ingredient, maintaining therapeutic plasma concentrations over an extended period and improving patient compliance by reducing dosing frequency. Macorate CR 200 is indicated for the treatment of various seizure types, including generalized tonic-clonic, absence, and complex partial seizures. It is also prescribed as a mood stabilizer in bipolar affective disorder to reduce the frequency and severity of manic episodes. Additionally, it may be used off-label for migraine prophylaxis. Common side effects include gastrointestinal disturbances, weight gain, tremors, and sedation, while serious adverse effects may involve hepatotoxicity, pancreatitis, and thrombocytopenia, necessitating regular monitoring of liver function tests and blood counts during therapy. Macorate CR 200 should be used under medical supervision, with dose adjustments based on clinical response and tolerability. It is contraindicated in patients with known hypersensitivity to valproate or significant hepatic impairment.